|Podcasts|August 23, 2022
SMO, A Model Sustained By Necessity
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Ian Smith MBE MB ChB.B MedSc(Hons), Founder, Director and Chief Medical Officer of Panthera Biopartners, and Chris Dodd, the company's Chief Commercial Officer, discuss the evolution of the Site Management Organization and Panthera Biopartners, how clinical trials remain mired in underperformance and difficulties, and hybrid trial advancements.
Related Content
Trending on Applied Clinical Trials Online
1
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
2
Where AI Has the Most Immediate Impact in Phase I Execution
3
FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices
4
When the Slack Runs Out: AI and the CRO Operating Model
5